Form 8-K Immunovant, Inc. For: Jun 01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
- Qualcomm shares fall on Intel warning and legal concerns
- Marvell Technology shares drop on Lumentum deal concerns
- Oracle shares drop on AI spending concerns and Microsoft criticism
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- SpaceX stock drops on launch setback and sector selloff
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Raymond James Downgrades Immunovant (IMVT) to Market Perform
June 1, 2021 3:31 PM EDTRaymond James analyst Danielle Brill downgraded Immunovant (NASDAQ: IMVT) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Immunovant click here. For more ratings news on Immunovant click here.
Shares of Immunovant closed at $15.16 yesterday.
... MoreGuggenheim Downgrades Immunovant (IMVT) to Neutral
June 1, 2021 1:22 PM EDTGuggenheim analyst Yatin Suneja downgraded Immunovant (NASDAQ: IMVT) from Buy to Neutral.
For an analyst ratings summary and ratings history on Immunovant click here. For more ratings news on Immunovant click here.
Shares of Immunovant closed at $15.16 yesterday.
... MoreImmunovant (IMVT) PT Lowered to $24 at Truist Securities
June 1, 2021 11:45 AM EDTTruist Securities analyst Robyn Karnauskas lowered the price target on Immunovant (NASDAQ: IMVT) to $24.00 (from $48.00) while maintaining a Buy rating on the disappointing TED news.
The analyst commented, "TED data likely a disappointment, given prior due-diligence indicating a potential oppy in... More



